WO2006128455A3 - Compounds modifying apoptosis - Google Patents
Compounds modifying apoptosis Download PDFInfo
- Publication number
- WO2006128455A3 WO2006128455A3 PCT/DK2006/000280 DK2006000280W WO2006128455A3 WO 2006128455 A3 WO2006128455 A3 WO 2006128455A3 DK 2006000280 W DK2006000280 W DK 2006000280W WO 2006128455 A3 WO2006128455 A3 WO 2006128455A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- apoptosis
- compounds
- compounds modifying
- modifying apoptosis
- inhibiting
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
- C07K5/1008—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/04—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers
- C07K1/047—Simultaneous synthesis of different peptide species; Peptide libraries
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0802—Tripeptides with the first amino acid being neutral
- C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
- C07K5/0806—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
Abstract
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2006254538A AU2006254538A1 (en) | 2005-05-25 | 2006-05-23 | Compounds modifying apoptosis |
US11/914,994 US8318717B2 (en) | 2005-05-25 | 2006-05-23 | Compounds modifying apoptosis |
EP06742429.1A EP1888619B1 (en) | 2005-05-25 | 2006-05-23 | Compounds modifying apoptosis |
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DKPCT/DK2005/000347 | 2005-05-25 | ||
DKPA200500763 | 2005-05-25 | ||
DKPA200500763 | 2005-05-25 | ||
PCT/DK2005/000347 WO2005116656A1 (en) | 2004-05-25 | 2005-05-25 | Identification of compounds modifying a cellular response |
DKPA200501663 | 2005-11-25 | ||
DKPA200501663 | 2005-11-25 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2006128455A2 WO2006128455A2 (en) | 2006-12-07 |
WO2006128455A3 true WO2006128455A3 (en) | 2007-04-12 |
Family
ID=37482012
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/DK2006/000280 WO2006128455A2 (en) | 2005-05-25 | 2006-05-23 | Compounds modifying apoptosis |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP1888619B1 (en) |
AU (1) | AU2006254538A1 (en) |
WO (1) | WO2006128455A2 (en) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1773766B1 (en) | 2004-07-15 | 2014-04-02 | Tetralogic Pharmaceuticals Corporation | Iap binding compounds |
JP5198880B2 (en) | 2005-02-25 | 2013-05-15 | テトラロジック ファーマシューティカルズ コーポレーション | Dimer IAP inhibitor |
WO2006122408A1 (en) | 2005-05-18 | 2006-11-23 | Aegera Therapeutics Inc. | Bir domain binding compounds |
BRPI0617751A2 (en) | 2005-10-25 | 2011-08-02 | Aegera Therapeutics Inc | iap bir domain binding compounds |
TWI543988B (en) | 2006-03-16 | 2016-08-01 | 科學製藥股份有限公司 | Iap bir domain binding compounds |
NZ572836A (en) | 2006-05-16 | 2011-12-22 | Pharmascience Inc | Iap bir domain binding compounds |
EP2049524A2 (en) | 2006-07-24 | 2009-04-22 | Tetralogic Pharmaceuticals Corporation | Iap inhibitors |
MX2009000824A (en) | 2006-07-24 | 2009-02-04 | Tetralogic Pharmaceuticals Cor | Dimeric iap antagonists. |
UY32099A (en) | 2008-09-11 | 2010-04-30 | Enanta Pharm Inc | HEPATITIS C SERINA PROTEASAS MACROCYCLIC INHIBITORS |
GB2472563B (en) * | 2009-04-28 | 2013-02-27 | Univ Leicester | Method of preparing hairpin and cyclic polyamides |
US8283372B2 (en) | 2009-07-02 | 2012-10-09 | Tetralogic Pharmaceuticals Corp. | 2-(1H-indol-3-ylmethyl)-pyrrolidine dimer as a SMAC mimetic |
UY32826A (en) | 2009-08-04 | 2011-02-28 | Takeda Pharmaceutical | HETEROCYCLIC COMPOUNDS |
EP2534170B1 (en) | 2010-02-12 | 2017-04-19 | Pharmascience Inc. | Iap bir domain binding compounds |
EP2658859A4 (en) | 2010-12-30 | 2014-07-30 | Enanta Pharm Inc | Macrocyclic hepatitis c serine protease inhibitors |
BR112013016480A2 (en) | 2010-12-30 | 2016-09-20 | Abbvie Inc | phenanthridine macrocycle hepatitis c serine protease inhibitors |
US10201584B1 (en) | 2011-05-17 | 2019-02-12 | Abbvie Inc. | Compositions and methods for treating HCV |
KR20140011773A (en) * | 2012-07-19 | 2014-01-29 | 한미약품 주식회사 | Heterocyclic derivatives with dual inhibitory activity |
WO2015103490A1 (en) | 2014-01-03 | 2015-07-09 | Abbvie, Inc. | Solid antiviral dosage forms |
WO2015109391A1 (en) | 2014-01-24 | 2015-07-30 | Children's Hospital Of Eastern Ontario Research Institute Inc. | Smc combination therapy for the treatment of cancer |
EP4093394A1 (en) | 2020-01-20 | 2022-11-30 | Astrazeneca AB | Epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of cancer |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0695757A2 (en) * | 1994-08-01 | 1996-02-07 | Arizona Board Of Regents | Human cancer inhibitory peptide amides |
WO2002096930A2 (en) * | 2001-05-31 | 2002-12-05 | The Trustees Of Princeton University | Iap binding peptides and assays for identifying compounds that bind iap |
WO2004005248A1 (en) * | 2002-07-02 | 2004-01-15 | Novartis Ag | Peptide inhibitors of smac protein binding to inhibitor of apoptosis proteins (iap) |
WO2004072105A2 (en) * | 2003-02-12 | 2004-08-26 | The Trustees Of Princeton University | Iap-binding cargo molecules and peptidomimetics for use in diagnostic and therapeutic methods |
WO2005116656A1 (en) * | 2004-05-25 | 2005-12-08 | 2Curex | Identification of compounds modifying a cellular response |
-
2006
- 2006-05-23 EP EP06742429.1A patent/EP1888619B1/en active Active
- 2006-05-23 WO PCT/DK2006/000280 patent/WO2006128455A2/en active Application Filing
- 2006-05-23 AU AU2006254538A patent/AU2006254538A1/en not_active Abandoned
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0695757A2 (en) * | 1994-08-01 | 1996-02-07 | Arizona Board Of Regents | Human cancer inhibitory peptide amides |
WO2002096930A2 (en) * | 2001-05-31 | 2002-12-05 | The Trustees Of Princeton University | Iap binding peptides and assays for identifying compounds that bind iap |
WO2004005248A1 (en) * | 2002-07-02 | 2004-01-15 | Novartis Ag | Peptide inhibitors of smac protein binding to inhibitor of apoptosis proteins (iap) |
WO2004072105A2 (en) * | 2003-02-12 | 2004-08-26 | The Trustees Of Princeton University | Iap-binding cargo molecules and peptidomimetics for use in diagnostic and therapeutic methods |
WO2005116656A1 (en) * | 2004-05-25 | 2005-12-08 | 2Curex | Identification of compounds modifying a cellular response |
Non-Patent Citations (3)
Title |
---|
BRIAN MCRAE ET AL.: "Studies on Reactivity of Human Leukocyte Elastase, Cathepsin G, and Procine Pancreatic Elastase toward Peptides Including Sequences Related to the Reactive Site of alpha1-Protease Inhibitor (alpha1-Antitrypsin)", BIOCHEMISTRY, vol. 19, 1980, pages 3973 - 3978, XP002415587 * |
GROTH T ET AL: "PEG BASED RESINS FOR PROTEASE DRUG DISCOVERY SYNTHESIS, SCREENING AND ANALYSIS OF COMBINATORIAL ON-BEAD LIBRARIES", COMBINATORIAL CHEMISTRY AND HIGH THROUGHPUT SCREENING, HILVERSUM, NL, vol. 6, no. 7, November 2003 (2003-11-01), pages 589 - 610, XP008033922, ISSN: 1386-2073 * |
KIPP R A ET AL: "Molecular targeting of inhibitor of apoptosis based on small molecule mimics of natural binding partners", BIOCHEMISTRY, AMERICAN CHEMICAL SOCIETY. EASTON, PA, US, vol. 41, no. 23, 2002, pages 7344 - 7349, XP002962287, ISSN: 0006-2960 * |
Also Published As
Publication number | Publication date |
---|---|
WO2006128455A2 (en) | 2006-12-07 |
EP1888619B1 (en) | 2013-04-17 |
AU2006254538A1 (en) | 2006-12-07 |
EP1888619A2 (en) | 2008-02-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2006128455A3 (en) | Compounds modifying apoptosis | |
WO2007081974A3 (en) | Viral hepatitis treatment | |
WO2009155001A3 (en) | Wnt protein signalling inhibitors | |
WO2009064486A3 (en) | Inhibitors of pim protein kinases, compositions, and methods for treating cancer | |
WO2007075525A3 (en) | Combination of an iap-inhibitor and a taxane7 | |
WO2007067781A3 (en) | 9-membered heterobicyclic compounds as inhibitors of protein kinases | |
WO2007064872A3 (en) | Urea compounds useful in the treatment of cancer | |
WO2007149482A3 (en) | Xanthohumol based protein kinase modulation cancer treatment | |
WO2007079164A3 (en) | Protein kinase inhibitors | |
WO2006107451A3 (en) | Honokiol derivatives for the treatment of proliferative disorders | |
WO2006102504A3 (en) | Combinations for the treatment of cancer comprising anti-egfr antibody and vegfr inhibitors | |
WO2006020060A3 (en) | Iap binding compounds | |
WO2008133663A3 (en) | Codon modified immunogenic compositions and methods of use | |
WO2006113483A3 (en) | Methods and compositions for treating or preventing cancer | |
WO2006004833A3 (en) | Pyrrolotriazine kinase inhibitors | |
WO2008076278A3 (en) | Methods of cancer treatment with igf1r inhibitors | |
WO2006104945A3 (en) | Hepatitis c therapies | |
WO2008128072A3 (en) | Axl kinase inhibitors useful for the treatment of cancer or hyperproliferative disorders | |
WO2007061874A3 (en) | Methods and compositions for use in treating cancer | |
WO2006072615A3 (en) | Triazolophthalazines as pde2-inhibitors | |
PL2231636T3 (en) | Pyrazole derivatives and use thereof as inhibitors of cyclin dependent kinases | |
WO2006119510A3 (en) | Isoforms of receptor for advanced glycation end products (rage) and methods of identifying and using same | |
ATE432281T1 (en) | PYRROLOTRIAZINE KINASE INHIBITORS | |
WO2007016674A3 (en) | 2-aminoaryl pyridines as protein kinases inhibitors | |
WO2008061108A3 (en) | Phthalazine derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2006254538 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2006742429 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: RU |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: RU |
|
ENP | Entry into the national phase |
Ref document number: 2006254538 Country of ref document: AU Date of ref document: 20060523 Kind code of ref document: A |
|
WWP | Wipo information: published in national office |
Ref document number: 2006254538 Country of ref document: AU |
|
WWP | Wipo information: published in national office |
Ref document number: 2006742429 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 11914994 Country of ref document: US |